Skip to main content
Log in

Corticosteroids are essential when treating patients with giant cell arteritis or polymyalgia rheumatica

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1
Fig. 2

References

  1. Schmidt J, Warrington K. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management. Drugs Aging 2011; 28(8): 651–66

    Article  PubMed  CAS  Google Scholar 

  2. Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 2010 Aug; 49(8): 1594–7

    Article  Google Scholar 

  3. Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 2010 Jan; 49(1): 186–90

    Article  Google Scholar 

  4. Weyand C, Goronzy J. Giant cell arteritis, polymyalgia rheumatica, and Takayasu’s arteritis. In: Klippel J, Stone J, Crofford L, et al., editors. Primer on the rheumatic diseases. New York (NY): Springer, 2008: 398–409

    Chapter  Google Scholar 

  5. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of literature. Acta Ophthalmol Scand 2002 Aug; 80(4): 355–67

    Article  PubMed  Google Scholar 

  6. Caporali R, Cimmino MA, Ferraccioli G, et al. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2004 Oct 5; 141(7): 493–500

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corticosteroids are essential when treating patients with giant cell arteritis or polymyalgia rheumatica. Drugs Ther Perspect 28, 11–14 (2012). https://doi.org/10.2165/11208740-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11208740-000000000-00000

Navigation